Brief: OSE Immunotherapeutics Appoints Dominique Costantini As Interim CEO

Ose Immunotherapeutics SA

17/01/2022 06:44

Jan 17 (Reuters) - OSE Immunotherapeutics SA  OSE.PA :
    * ANNOUNCES THE APPOINTMENT OF DOMINIQUE COSTANTINI AS
INTERIM CEO
FOLLOWING THE DEPARTURE OF ALEXIS PEYROLES
    * DOMINIQUE COSTANTINI, CURRENT CHAIRWOMAN OF OSE
IMMUNOTHERAPEUTICS' BOARD OF DIRECTORS, AND PREVIOUSLY CEO FROM
2012 TO 2018, HAS BEEN APPOINTED INTERIM CHIEF EXECUTIVE
OFFICER, EFFECTIVE IMMEDIATELY
    * A SEARCH FOR A NEW CEO HAS BEEN LAUNCHED WITH ASSISTANCE
OF A
LEADING EXECUTIVE SEARCH FIRM
    * ALEXIS PEYROLES IS STEPPING DOWN FOR HEALTH REASONS AND HE
REMAINS COMMITTED TO OSE'S SUCCESS. HE WILL CONTINUE TO SUPPORT
COMPANY IN A CONSULTING CAPACITY FOR UPCOMING MONTHS TO ENSURE A
SMOOTH TRANSITION

Source text for Eikon:  urn:newsml:reuters.com:*:nBw7lMfzfa
Further company coverage:  OSE.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48587696600;))